Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain [Phase 4]
A Phase 4 trial evaluating ambulatory infusions of lidocaine and ketamine for chronic neuropathic pain and fibromyalgia has been completed.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Treatment of Pain Associated With Fibromyalgia [Phase 3]
Phase 3 trial update for treatment of pain associated with fibromyalgia; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Treatment of Pain Associated With Fibromyalgia [Phase 3]
Phase 3 clinical trial update for a treatment targeting pain associated with fibromyalgia; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Treatment of Pain Associated With Fibromyalgia [Phase 3]
Phase 3 clinical trial update for a treatment addressing pain associated with fibromyalgia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Neurologic Signatures of Chronic Pain Disorders [Phase 4]
Phase 4 clinical trial update on neurologic signatures of chronic pain disorders, including chronic pain, chronic migraine, and fibromyalgia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease [Phase 3]
Phase 3 safety study of DS-5565 for fibromyalgia in patients with chronic kidney disease has completed with results posted.
-
FDA approval · 2020-10-01FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: LDN and tDCS in Fibromyalgia [Phase 2, Phase 3]
A completed clinical trial update involving LDN and tDCS in fibromyalgia across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Feasibility Study: fMRI Evaluation of Auricular PENFS for Fibromyalgia [NA]
A feasibility study evaluating fMRI responses to auricular PENFS in fibromyalgia has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia [Phase 3]
Open-label extension study of DS-5565 for 52 weeks in adults with pain associated with fibromyalgia completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS. [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of Vitamin D3 in women with fibromyalgia, using FIQ and VAS for assessment.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) in Fibromyalgia [NA]
Clinical trial results for repetitive transcranial magnetic stimulation (rTMS) in fibromyalgia have been completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Evaluation of Smell and Taste in Fibromyalgia
A completed clinical trial evaluating smell and taste in patients with fibromyalgia; results posted in 2020.
-
FDA approval · 2020-04-20FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly, granting updated labeling under the NDA.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Association of Ferritin Levels With Clinical Parameters in Patients With Fibromyalgia Syndrome
A completed clinical trial investigating the association of ferritin levels with clinical parameters in patients with fibromyalgia syndrome.
-
FDA approval · 2020-04-03FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental NDA for LYRICA CR (pregabalin) submitted by Viatris Specialty LLC, indicating a regulatory approval of a supplem…
-
FDA approval · 2020-03-23FDA Approved: PREGABALIN — Original Application (Creekwood Pharmaceuticals LLC)
FDA approves Creekwood Pharmaceuticals LLC's Original Application (ANDA) for pregabalin, enabling a generic version of the drug. This action…
-
FDA approval · 2020-03-20FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Low-level Laser Therapy in Patients With Chronic Fibromyalgia [NA]
Clinical trial update on low-level laser therapy for chronic pain in fibromyalgia patients; the study is terminated with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia [Phase 2, Phase 3]
A clinical trial comparing duloxetine with escitalopram in fibromyalgia was completed (Phase 2/Phase 3).
-
CLINICAL_TRIALS research · 2020-02-24Clinical Trial Update: Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial [NA]
A completed clinical trial comparing yoga to structured exercise for pain outcomes in fibromyalgia, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Use of Whole Body Vibration in Patients With Fibromyalgia [NA]
A completed clinical trial evaluating the use of whole body vibration in patients with fibromyalgia; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment. [Phase 2]
Phase II clinical trial investigating KL16-012 in women with fibromyalgia refractory to conventional treatment.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: Study of Fibromyalgia Treated With Milnacipran [Phase 4]
Phase 4 clinical trial update for Milnacipran in the treatment of fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia [Phase 3]
Open-label extension study update for S,S-Reboxetine in fibromyalgia (Phase 3) terminated.